Dalbavancin is a semi-synthetic lipoglycopeptide antimicrobial agent that was approved by FDA for the treatment of acute bacterial skin and skin structure infections caused by Gram-positive organisms.
ESBL positive and Carbapenemases positive Enterobacteriaceae (CPE) have now become a global concern. CPE are often express MDR and XDR phenotypes with increasing reports of pan-resistance.
The incidence of infections with multidrug resistant (MDR) Enterobacteriaceae has risen considerably in recent years, associated mostly with ESBL production.
The Commercial Kit SIRE Nitratase® PlastLabor, is a drug susceptibility test kit used to detect Mycobacterium tuberculosis resistance to first-line TB treatment drugs. The present study aimed at evaluating its performance in a multicenter study.